Fundz

Akero Therapeutics, Inc. reported raising $45.5 Million in an initial SEC Form D filing, from an offering of $45.5 Million

RECENTLY ACQUIREDDec 18, 2018

Amount Raised

$45.5 Million

$45.5 Million sold, per SEC Form D (first sale Dec 18, 2018)

Round Type

Venture

South San FranciscoBiotechnologyHealth CareTherapeutics

Quick answer

Akero Therapeutics raised $45.5 Million in a funding round, dated December 18, 2018. Akero Therapeutics is based in South San Francisco, California, United States.

How much did Akero Therapeutics raise?
Akero Therapeutics raised $45.5 Million in a funding round on December 18, 2018.
What does Akero Therapeutics do?
Akero Therapeutics, Inc. is a clinical-stage company developing transformational treatments for patients with serious metabolic disease.
Where is Akero Therapeutics based and how big is it?
Akero Therapeutics is based in South San Francisco, California, United States.
Who are the decision-makers at Akero Therapeutics?
Fundz holds 3 contacts at Akero Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Akero Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Immunome Inc. raised an undisclosed amount on February 1, 2019.
  • Alcresta Therapeutics raised $5M on January 23, 2019.
  • Turnstone Biologics Corp raised $42M on January 18, 2019.
  • Summit Therapeutics raised $25M on January 18, 2019.
  • BioCardia raised $4M (Seed) on January 7, 2019.
  • vTv Therapeutics Inc. raised $1.5M (Seed) on January 4, 2019.

Who to call at Akero Therapeutics, and when

A new round usually means Akero Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Akero Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Akero Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Akero Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Akero Therapeutics

Location

South San Francisco, California, United States

About

Akero Therapeutics, Inc. is a clinical-stage company developing transformational treatments for patients with serious metabolic disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Akero Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Akero Therapeutics's next move

See what Strategic adds

Akero Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.